Amr Hanbali

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Venues

International journal of hematologic oncology

EJHaem

Advances in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Amr Hanbali, Ahmed Kotb, Riad El Fakih, Feras Alfraih, Nahla Shihata, Walid Rasheed, Syed Osman Ahmed, Marwan Shaheen, Saud Alhayli, Ali Alahmari, Ahmad Alotaibi, Alfadel Alshaibani, Abdulwahab Albabtain, Mansour Alfayez, Maha Hassan, Fahad Alsharif, Naeem Chaudhri, Fahad Almohareb, Hazzaa Alzahrani, Mahmoud Aljurf
Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia. International journal of hematologic oncology 12 (1) (2023)
Amr Hanbali, Ahmed Kotb, Riad El Fakih, Feras Alfraih, Nahla Shihata, Walid Rasheed, Syed Osman Ahmed, Marwan Shaheen, Saud Alhayli, Ali Alahmari, Ahmad Alotaibi, Alfadel Alshaibani, Abdulwahab Albabtain, Mansour Alfayez, Maha Hassan, Fahad Alsharif, Naeem Chaudhri, Fahad Almohareb, Hazzaa Alzahrani, Mahmoud Aljurf
Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia. International journal of hematologic oncology 12 (1) (2023)
Mona Hassanein, Riad El Fakih, Walid Rasheed, Syed Ahmed, Marwan Shaheen, Naeem Chaudhri, Fahad Alsharif, Shad Ahmed, Amr Hanbali, Alfadel AlShaibani, Feras Alfraih, Saud Alhayli, Tusneem Elhassan, Ali Alahmari, Hazzaa Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Shahrukh Hashmi
The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor-risk cytogenetic abnormalities. EJHaem 2 (2) (2021)
Amr Hanbali, Mona Hassanein, Walid Rasheed, Mahmoud Aljurf, Fahad Alsharif
The Evolution of Prognostic Factors in Multiple Myeloma. Advances in hematology 2017 (2017)

Amr Hanbali.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amr Hanbali